BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boutrel B, de Lecea L. Addiction and arousal: the hypocretin connection. Physiol Behav. 2008;93:947-951. [PMID: 18262574 DOI: 10.1016/j.physbeh.2007.11.022] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Lawrence AJ. Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Res 2010;1314:124-9. [PMID: 19646424 DOI: 10.1016/j.brainres.2009.07.072] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
2 Wang B, You ZB, Wise RA. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol Psychiatry 2009;65:857-62. [PMID: 19251246 DOI: 10.1016/j.biopsych.2009.01.018] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 6.7] [Reference Citation Analysis]
3 Sperling W, Biermann T. Influenza H1N1 and the world wide economic crisis--a model of coherence? Med Hypotheses 2009;73:664-6. [PMID: 19515500 DOI: 10.1016/j.mehy.2009.05.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Farahimanesh S, Karimi S, Haghparast A. Role of orexin-1 receptors in the dorsal hippocampus (CA1 region) in expression and extinction of the morphine-induced conditioned place preference in the rats. Peptides 2018;101:25-31. [DOI: 10.1016/j.peptides.2017.12.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
5 Chen X, Wang H, Lin Z, Li S, Li Y, Bergen HT, Vrontakis ME, Kirouac GJ. Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks. Brain Struct Funct 2014;219:2103-18. [PMID: 23955372 DOI: 10.1007/s00429-013-0626-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
6 Rapaka R, Schnur P, Shurtleff D. Obesity and addiction: Common neurological mechanisms and drug development. Physiology & Behavior 2008;95:2-9. [DOI: 10.1016/j.physbeh.2008.05.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
7 Adamantidis A, Carter MC, de Lecea L. Optogenetic deconstruction of sleep-wake circuitry in the brain. Front Mol Neurosci 2010;2:31. [PMID: 20126433 DOI: 10.3389/neuro.02.031.2009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
8 Dhaher R, Hauser SR, Getachew B, Bell RL, McBride WJ, McKinzie DL, Rodd ZA. The Orexin-1 Receptor Antagonist SB-334867 Reduces Alcohol Relapse Drinking, but not Alcohol-Seeking, in Alcohol-Preferring (P) Rats. J Addict Med 2010;4:153-9. [PMID: 20871792 DOI: 10.1097/ADM.0b013e3181bd893f] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
9 Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P, Richardson KA. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res 2010;1314:74-90. [PMID: 19815001 DOI: 10.1016/j.brainres.2009.09.106] [Cited by in Crossref: 238] [Cited by in F6Publishing: 242] [Article Influence: 18.3] [Reference Citation Analysis]
10 Borer KT. Counterregulation of insulin by leptin as key component of autonomic regulation of body weight. World J Diabetes 2014; 5(5): 606-629 [PMID: 25317239 DOI: 10.4239/wjd.v5.i5.606] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
11 McGregor R, Thannickal TC, Siegel JM. Pleasure, addiction, and hypocretin (orexin). Handb Clin Neurol 2021;180:359-74. [PMID: 34225941 DOI: 10.1016/B978-0-12-820107-7.00022-7] [Reference Citation Analysis]
12 Moore CF, Panciera JI, Sabino V, Cottone P. Neuropharmacology of compulsive eating. Philos Trans R Soc Lond B Biol Sci 2018;373:20170024. [PMID: 29352024 DOI: 10.1098/rstb.2017.0024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
13 Perrey DA, Gilmour BP, Runyon SP, Thomas BF, Zhang Y. Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists. Bioorg Med Chem Lett 2011;21:2980-5. [PMID: 21478014 DOI: 10.1016/j.bmcl.2011.03.048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
14 Adamantidis A, de Lecea L. Sleep and metabolism: shared circuits, new connections. Trends Endocrinol Metab 2008;19:362-70. [PMID: 18938086 DOI: 10.1016/j.tem.2008.08.007] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
15 El Firar A, Voisin T, Rouyer-fessard C, Ostuni MA, Couvineau A, Laburthe M. Discovery of a functional immunoreceptor tyrosine‐ based switch motif in a 7‐transmembrane‐spanning receptor: role in the orexin receptor OX1R‐driven apoptosis. FASEB j 2009;23:4069-80. [DOI: 10.1096/fj.09-131367] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
16 Baldo BA. Prefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis. Trends Neurosci 2016;39:366-77. [PMID: 27233653 DOI: 10.1016/j.tins.2016.03.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
17 Mediavilla C, Cabello V, Risco S. SB-334867-A, a selective orexin-1 receptor antagonist, enhances taste aversion learning and blocks taste preference learning in rats. Pharmacol Biochem Behav 2011;98:385-91. [PMID: 21295056 DOI: 10.1016/j.pbb.2011.01.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
18 Urbano FJ, Bisagno V, Garcia-Rill E. Arousal and drug abuse. Behav Brain Res 2017;333:276-81. [PMID: 28729115 DOI: 10.1016/j.bbr.2017.07.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
19 Perrey DA, German NA, Gilmour BP, Li JX, Harris DL, Thomas BF, Zhang Y. Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. J Med Chem 2013;56:6901-16. [PMID: 23941044 DOI: 10.1021/jm400720h] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
20 Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Prog Brain Res 2012;198:79-121. [PMID: 22813971 DOI: 10.1016/B978-0-444-59489-1.00007-0] [Cited by in Crossref: 140] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
21 Boutrel B, Cannella N, de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res 2010;1314:103-11. [PMID: 19948148 DOI: 10.1016/j.brainres.2009.11.054] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 6.5] [Reference Citation Analysis]
22 Figlewicz DP, Benoit SC. Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol. 2009;296:R9-R19. [PMID: 18945945 DOI: 10.1152/ajpregu.90725.2008] [Cited by in Crossref: 135] [Cited by in F6Publishing: 129] [Article Influence: 9.6] [Reference Citation Analysis]
23 Wheeler DS, Wan S, Miller A, Angeli N, Adileh B, Hu W, Holland PC. Role of lateral hypothalamus in two aspects of attention in associative learning. Eur J Neurosci 2014;40:2359-77. [PMID: 24750426 DOI: 10.1111/ejn.12592] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
24 Bayerlein K, Kraus T, Leinonen I, Pilniok D, Rotter A, Hofner B, Schwitulla J, Sperling W, Kornhuber J, Biermann T. Orexin A expression and promoter methylation in patients with alcohol dependence comparing acute and protracted withdrawal. Alcohol 2011;45:541-7. [DOI: 10.1016/j.alcohol.2011.02.306] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
25 Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 2016;3:760-73. [PMID: 27475769 DOI: 10.1016/S2215-0366(16)00104-8] [Cited by in Crossref: 1089] [Cited by in F6Publishing: 574] [Article Influence: 217.8] [Reference Citation Analysis]
26 Dodge K, Krantz B, Kenny PJ. How can we begin to measure recovery? Subst Abuse Treat Prev Policy 2010;5:31. [PMID: 21138568 DOI: 10.1186/1747-597X-5-31] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV. Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls. Front Neurosci 2014;8:36. [PMID: 24616658 DOI: 10.3389/fnins.2014.00036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
28 Boss C, Roch-brisbare C, Steiner MA, Treiber A, Dietrich H, Jenck F, von Raumer M, Sifferlen T, Brotschi C, Heidmann B, Williams JT, Aissaoui H, Siegrist R, Gatfield J. Structure-Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT-462206: a Potent, Brain-Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist. ChemMedChem 2014;9:2486-96. [DOI: 10.1002/cmdc.201402258] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
29 Gatfield J, Brisbare-Roch C, Jenck F, Boss C. Orexin receptor antagonists: a new concept in CNS disorders? ChemMedChem 2010;5:1197-214. [PMID: 20544785 DOI: 10.1002/cmdc.201000132] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
30 Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
31 Schmeichel BE, Matzeu A, Koebel P, Vendruscolo LF, Sidhu H, Shahryari R, Kieffer BL, Koob GF, Martin-Fardon R, Contet C. Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats. Neuropsychopharmacology 2018;43:2373-82. [PMID: 29703996 DOI: 10.1038/s41386-018-0054-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
32 Hoyer D, Jacobson LH. Orexin Receptor Antagonists. Curr Sleep Medicine Rep 2017;3:342-53. [DOI: 10.1007/s40675-017-0099-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Shalev U, Erb S, Shaham Y. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res 2010;1314:15-28. [PMID: 19631614 DOI: 10.1016/j.brainres.2009.07.028] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 7.5] [Reference Citation Analysis]
34 Rácz I. Neuroplastic changes in addiction. Front Mol Neurosci 2014;6:56. [PMID: 24427114 DOI: 10.3389/fnmol.2013.00056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Young CE, Tong Q. Corticotropin Releasing Hormone Signaling in the Bed Nuclei of the Stria Terminalis as a Link to Maladaptive Behaviors. Front Neurosci 2021;15:642379. [PMID: 33867924 DOI: 10.3389/fnins.2021.642379] [Reference Citation Analysis]
36 Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Res 2010;1314:91-102. [PMID: 19748490 DOI: 10.1016/j.brainres.2009.09.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
37 Figlewicz DP, Sipols AJ. Energy regulatory signals and food reward. Pharmacol Biochem Behav. 2010;97:15-24. [PMID: 20230849 DOI: 10.1016/j.pbb.2010.03.002.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, Chou J, Chen BT, Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 2009;29:11215-25. [PMID: 19741128 DOI: 10.1523/JNEUROSCI.6096-08.2009] [Cited by in Crossref: 245] [Cited by in F6Publishing: 162] [Article Influence: 18.8] [Reference Citation Analysis]
39 Adamantidis A, de Lecea L. The hypocretins as sensors for metabolism and arousal. J Physiol 2009;587:33-40. [PMID: 19047201 DOI: 10.1113/jphysiol.2008.164400] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
40 Kenny PJ. Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav 2011;97:700-7. [PMID: 20816891 DOI: 10.1016/j.pbb.2010.08.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
41 Van Vugt DA. Brain imaging studies of appetite in the context of obesity and the menstrual cycle. Human Reproduction Update 2010;16:276-92. [DOI: 10.1093/humupd/dmp051] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
42 Bonnavion P, Mickelsen LE, Fujita A, de Lecea L, Jackson AC. Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour. J Physiol 2016;594:6443-62. [PMID: 27302606 DOI: 10.1113/JP271946] [Cited by in Crossref: 95] [Cited by in F6Publishing: 53] [Article Influence: 15.8] [Reference Citation Analysis]
43 Li Y, Li S, Sui N, Kirouac GJ. Orexin-A acts on the paraventricular nucleus of the midline thalamus to inhibit locomotor activity in rats. Pharmacol Biochem Behav 2009;93:506-14. [PMID: 19604495 DOI: 10.1016/j.pbb.2009.06.017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
44 Yadid G, Redlus L, Barnea R, Doron R. Modulation of mood States as a major factor in relapse to substance use. Front Mol Neurosci 2012;5:81. [PMID: 22837738 DOI: 10.3389/fnmol.2012.00081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
45 Zarrabian S, Riahi E, Karimi S, Razavi Y, Haghparast A. The potential role of the orexin reward system in future treatments for opioid drug abuse. Brain Research 2020;1731:146028. [DOI: 10.1016/j.brainres.2018.11.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
46 Figlewicz DP, Sipols AJ. Energy regulatory signals and food reward. Pharmacol Biochem Behav 2010;97:15-24. [PMID: 20230849 DOI: 10.1016/j.pbb.2010.03.002] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 6.8] [Reference Citation Analysis]
47 Mantyh WG, Auger RR, Morgenthaler TI, Silber MH, Moore WR. Examining the Frequency of Stimulant Misuse among Patients with Primary Disorders of Hypersomnolence: A Retrospective Cohort Study. J Clin Sleep Med 2016;12:659-62. [PMID: 26943713 DOI: 10.5664/jcsm.5788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
48 Boutrel B, Steiner N, Halfon O. The hypocretins and the reward function: what have we learned so far? Front Behav Neurosci 2013;7:59. [PMID: 23781178 DOI: 10.3389/fnbeh.2013.00059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
49 Abreu AR, Molosh AI, Johnson PL, Shekhar A. Role of medial hypothalamic orexin system in panic, phobia and hypertension. Brain Res 2020;1731:145942. [PMID: 30205108 DOI: 10.1016/j.brainres.2018.09.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
50 Li Y, Li S, Wei C, Wang H, Sui N, Kirouac GJ. Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl) 2010;212:251-65. [PMID: 20645079 DOI: 10.1007/s00213-010-1948-y] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 9.4] [Reference Citation Analysis]
51 Rao Y, Mineur YS, Gan G, Wang AH, Liu ZW, Wu X, Suyama S, de Lecea L, Horvath TL, Picciotto MR, Gao XB. Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin-producing neurons in the lateral hypothalamus in mice. J Physiol 2013;591:1951-66. [PMID: 23318871 DOI: 10.1113/jphysiol.2012.246983] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
52 Leri F, Zhou Y, Carmichael B, Cummins E, Kreek MJ. Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression. Eur Neuropsychopharmacol 2012;22:143-52. [PMID: 21745729 DOI: 10.1016/j.euroneuro.2011.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
53 Ponz A, Khatami R, Poryazova R, Werth E, Boesiger P, Bassetti CL, Schwartz S. Abnormal activity in reward brain circuits in human narcolepsy with cataplexy. Ann Neurol 2010;67:190-200. [DOI: 10.1002/ana.21825] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
54 Abizaid A, Mineur YS, Roth RH, Elsworth JD, Sleeman MW, Picciotto MR, Horvath TL. Reduced locomotor responses to cocaine in ghrelin-deficient mice. Neuroscience 2011;192:500-6. [PMID: 21699961 DOI: 10.1016/j.neuroscience.2011.06.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
55 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
56 Steenbergh TA, Runyan JD, Daugherty DA, Winger JG. Neuroscience exposure and perceptions of client responsibility among addictions counselors. J Subst Abuse Treat 2012;42:421-8. [PMID: 22116014 DOI: 10.1016/j.jsat.2011.09.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
57 Williams JT, Gatfield J, Roch C, Treiber A, Jenck F, Bolli MH, Brotschi C, Sifferlen T, Heidmann B, Boss C. Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists. Med Chem Commun 2015;6:1054-64. [DOI: 10.1039/c5md00074b] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
58 Li Y, Wang H, Qi K, Chen X, Li S, Sui N, Kirouac GJ. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal. Physiol Behav 2011;102:42-50. [PMID: 20951152 DOI: 10.1016/j.physbeh.2010.10.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
59 Bongaard BS. Mind Over Cupcake. EXPLORE 2008;4:267-72. [DOI: 10.1016/j.explore.2008.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Laburthe M, Voisin T, El Firar A. Orexins/hypocretins and orexin receptors in apoptosis: a mini-review. Acta Physiologica 2010;198:393-402. [DOI: 10.1111/j.1748-1716.2009.02035.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
61 Nair SG, Adams-Deutsch T, Epstein DH, Shaham Y. The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.Prog Neurobiol. 2009;89:18-45. [PMID: 19497349 DOI: 10.1016/j.pneurobio.2009.05.003] [Cited by in Crossref: 83] [Cited by in F6Publishing: 87] [Article Influence: 6.4] [Reference Citation Analysis]
62 Sorooshyari S, Huerta R, de Lecea L. A Framework for Quantitative Modeling of Neural Circuits Involved in Sleep-to-Wake Transition. Front Neurol 2015;6:32. [PMID: 25767461 DOI: 10.3389/fneur.2015.00032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
63 Zhang S, Hu S, Hu J, Wu PL, Chao HH, Li CS. Barratt Impulsivity and Neural Regulation of Physiological Arousal. PLoS One 2015;10:e0129139. [PMID: 26079873 DOI: 10.1371/journal.pone.0129139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
64 McGregor R, Wu MF, Barber G, Ramanathan L, Siegel JM. Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level. J Neurosci 2011;31:15455-67. [PMID: 22031892 DOI: 10.1523/JNEUROSCI.4017-11.2011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
65 Risco S, Mediavilla C. Orexin-1 receptor antagonist in central nucleus of the amygdala attenuates the acquisition of flavor-taste preference in rats. Pharmacol Biochem Behav 2014;126:7-12. [PMID: 25223979 DOI: 10.1016/j.pbb.2014.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
66 Ruisoto P, Contador I. The role of stress in drug addiction. An integrative review. Physiol Behav 2019;202:62-8. [PMID: 30711532 DOI: 10.1016/j.physbeh.2019.01.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
67 Zhou L, Sun WL, See RE. Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction. Pharmaceuticals (Basel) 2011;4:804-21. [PMID: 23997653 DOI: 10.3390/ph4060804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
68 Boss C, Brisbare-Roch C, Jenck F. Biomedical application of orexin/hypocretin receptor ligands in neuroscience. J Med Chem 2009;52:891-903. [PMID: 19199652 DOI: 10.1021/jm801296d] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]